$WKHS
Workhorse Group Inc. Stock $wkhs

$wkhs Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000142528724000131 Filed on November 19, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$2.510M	$3.029M
YoY Change		-17.13%	95.54%
Cost Of Revenue		$6.643M	$6.557M
YoY Change		1.3%	-31.09%
Gross Profit		-$4.133M	-$3.529M
YoY Change		17.12%	-55.71%
Gross Profit Margin		-164.67%	-116.52%
Selling, General & Admin		$7.722M	$11.76M
YoY Change		-34.32%	-66.17%
% of Gross Profit
Research & Development		$2.313M	$5.772M
YoY Change		-59.92%	-5.8%
% of Gross Profit
Depreciation & Amortization		$1.940M	$1.080M
YoY Change		79.66%	61.67%
% of Gross Profit
Operating Expenses		$10.04M	$17.53M
YoY Change		-42.75%	-57.12%
Operating Profit		-$14.17M	-$21.06M
YoY Change		-32.71%	-56.89%
Interest Expense		-$8.318M	$410.0K
YoY Change		-2128.73%
% of Operating Profit
Other Income/Expense, Net		$0.00	-$10.00M
YoY Change		-100.0%	-174.4%
Pretax Income		-$25.14M	-$30.65M
YoY Change		-17.98%	-13.44%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings		-$25.14M	-$30.65M
YoY Change		-17.98%	-13.44%
Net Earnings / Revenue		-1001.53%	-1011.9%
Basic Earnings Per Share		-$0.98	-$0.14
Diluted Earnings Per Share		-$0.98	-$0.14
COMMON SHARES
Basic Shares Outstanding	40.98M shares	24.36M shares	210.8M shares
Diluted Shares Outstanding		25.59M shares	215.9M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.245M	$38.90M
YoY Change	-91.66%	-67.62%
Cash & Equivalents	$3.200M	$38.90M
Short-Term Investments
Other Short-Term Assets	$1.614M	$612.8K
YoY Change	163.29%	-0.14%
Inventory	$43.20M	$40.78M
Prepaid Expenses
Receivables	$700.0K	$7.424M
Other Receivables	$3.002M	$0.00
Total Short-Term Assets	$57.47M	$97.78M
YoY Change	-41.22%	-40.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$34.83M	$37.47M
YoY Change	-7.04%	119.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00
YoY Change		-100.0%
Other Assets	$176.3K	$176.3K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$43.94M	$48.52M
YoY Change	-9.44%	25.37%
TOTAL ASSETS
Total Short-Term Assets	$57.47M	$97.78M
Total Long-Term Assets	$43.94M	$48.52M
Total Assets	$101.4M	$146.3M
YoY Change	-30.68%	-27.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.60M	$11.94M
YoY Change	-11.19%	54.45%
Accrued Expenses	$8.384M	$5.859M
YoY Change	43.11%	-86.93%
Deferred Revenue	$6.351M	$4.737M
YoY Change	34.07%	40.35%
Short-Term Debt	$13.18M	$0.00
YoY Change
Long-Term Debt Due	$2.101M
YoY Change
Total Short-Term Liabilities	$49.60M	$25.87M
YoY Change	91.71%	-57.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.557M	$7.700M
YoY Change	-40.82%	-24.82%
Total Long-Term Liabilities	$4.557M	$7.700M
YoY Change	-40.82%	-24.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$49.60M	$25.87M
Total Long-Term Liabilities	$4.557M	$7.700M
Total Liabilities	$54.15M	$33.53M
YoY Change	61.51%	-52.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$832.2M	-$706.3M
YoY Change	17.83%	19.92%
Common Stock	$31.86K	$255.4K
YoY Change	-87.52%	59.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$47.26M	$112.8M
YoY Change
Total Liabilities & Shareholders Equity	$101.4M	$146.3M
YoY Change	-30.68%	-27.53%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$25.14M	-$30.65M
YoY Change	-17.98%	-13.44%
Depreciation, Depletion And Amortization	$1.940M	$1.080M
YoY Change	79.66%	61.67%
Cash From Operating Activities	-$10.05M	-$29.75M
YoY Change	-66.21%	182.88%
INVESTING ACTIVITIES
Capital Expenditures	$268.2K	$6.060M
YoY Change	-95.57%	-249.63%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$268.2K	-$6.060M
YoY Change	-95.57%	-33.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	8.257M	12.28M
YoY Change	-32.76%	-3366.65%
NET CHANGE
Cash From Operating Activities	-10.05M	-29.75M
Cash From Investing Activities	-268.2K	-6.060M
Cash From Financing Activities	8.257M	12.28M
Net Change In Cash	-2.064M	-23.53M
YoY Change	-91.23%	17.99%
FREE CASH FLOW
Cash From Operating Activities	-$10.05M	-$29.75M
Capital Expenditures	$268.2K	$6.060M
Free Cash Flow	-$10.32M	-$35.81M
YoY Change	-71.18%	453.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Entity File Number EntityFileNumber	001-37673
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14299042	shares
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2761	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1978330	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001425287
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	WORKHORSE GROUP INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1394771
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3600 Park 42 Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 160E
	dei	Local Phone Number LocalPhoneNumber	646-5205
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	WKHS
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40981553	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3244806	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25845915	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14299042	shares
	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	8688423	usd
	us-gaap	Cost Of Revenue CostOfRevenue	21386676	usd
	us-gaap	Gross Profit GrossProfit	-16695225	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	33883845	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	40448651	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7834113	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18056182	usd
	us-gaap	Operating Expenses OperatingExpenses	41717958	usd
	us-gaap	Operating Expenses OperatingExpenses	58504833	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-58413183	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-70129264	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25135559	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-30645712	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.06
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10793926	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19879290	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19879290	shares
	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	45241
	dei	City Area Code CityAreaCode	888
CY2024Q3	us-gaap	Inventory Gross InventoryGross	55696621	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12510159	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	43186462	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	107387721	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1466839	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-7089027	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	usd
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25589725	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25589725	shares
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	47257883	usd
CY2024Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.05
CY2024Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.05
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3M
	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
CY2024Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.05
	dei	Entity Address City Or Town EntityAddressCityOrTown	Sharonville
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	6642549	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	-4132832	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-3528813	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7722014	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11756291	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2313423	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5771588	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	10035437	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	17527879	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14168269	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-21056692	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	410980	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-15109136	usd
CY2024Q3	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-2649477	usd
CY2023Q3	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80611346	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-25135559	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-30645712	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80611346	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.84
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.84
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9487842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9487842	shares
CY2023Q3	wkhs	Shares Issued During Period Value Litigation Settlement SharesIssuedDuringPeriodValueLitigationSettlement	20000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8376	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3520404	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-30645712	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	112768693	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	108586931	usd
	wkhs	Shares Issued During Period Shares Litigation Settlement SharesIssuedDuringPeriodSharesLitigationSettlement	1269036	shares
	wkhs	Shares Issued During Period Value Litigation Settlement SharesIssuedDuringPeriodValueLitigationSettlement	20000000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-467214	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10321889	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5470933	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5621181	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176310	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176310	usd
CY2023Q4	us-gaap	Assets Assets	141674724	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10572525	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12456272	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8384321	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4862740	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6350581	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4714331	usd
CY2024Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	776423	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1902647	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1001120	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1012428	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2100635	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2548184	usd
CY2024Q3	wkhs	Warrant Liability WarrantLiability	7229919	usd
CY2023Q4	wkhs	Warrant Liability WarrantLiability	5605325	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	13182467	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	20180100	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	49597991	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	53282027	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4556738	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5280526	usd
CY2024Q3	us-gaap	Liabilities Liabilities	54154729	usd
CY2023Q4	us-gaap	Liabilities Liabilities	58562553	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31862091	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31862091	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	14299	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	879405617	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	834666123	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-832179596	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-751568251	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	47257883	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	83112171	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	101412612	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	141674724	usd
CY2024Q3	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	2509717	usd
CY2023Q3	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	3028545	usd
	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	4691451	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	682673	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2326774	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3002143	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2143435	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	43186462	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	45408192	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7357838	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8101162	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	57473922	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	93825478	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34825810	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37876955	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3465637	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4174800	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5470933	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5621181	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176310	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176310	usd
CY2024Q3	us-gaap	Assets Assets	101412612	usd
CY2023Q4	us-gaap	Assets Assets	141674724	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10572525	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12456272	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8384321	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4862740	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6350581	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4714331	usd
CY2024Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	776423	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1902647	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1001120	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1012428	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2100635	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2548184	usd
CY2024Q3	wkhs	Warrant Liability WarrantLiability	7229919	usd
CY2023Q4	wkhs	Warrant Liability WarrantLiability	5605325	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	13182467	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	20180100	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	49597991	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	53282027	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4556738	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5280526	usd
CY2024Q3	us-gaap	Liabilities Liabilities	54154729	usd
CY2023Q4	us-gaap	Liabilities Liabilities	58562553	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31862091	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	31862	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	14299	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	879405617	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	834666123	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	47257883	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	83112171	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	101412612	usd
CY2024Q3	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	2509717	usd
CY2023Q3	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	3028545	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	6557358	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	-4132832	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-3528813	usd
	us-gaap	Gross Profit GrossProfit	-11624431	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7722014	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11756291	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2313423	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5771588	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	10035437	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	17527879	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14168269	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-21056692	usd
CY2024Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-8317813	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	410980	usd
CY2024Q3	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-2649477	usd
CY2023Q3	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80611346	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-78662425	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80611346	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.84
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.84
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.29
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10793926	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9487842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9487842	shares
CY2023Q3	wkhs	Shares Issued During Period Value Litigation Settlement SharesIssuedDuringPeriodValueLitigationSettlement	20000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8376	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-30645712	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	108586931	usd
	wkhs	Shares Issued During Period Shares Litigation Settlement SharesIssuedDuringPeriodSharesLitigationSettlement	1269036	shares
	wkhs	Shares Issued During Period Value Litigation Settlement SharesIssuedDuringPeriodValueLitigationSettlement	20000000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-467214	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	112768693	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	58636957	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-143	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-25135559	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-171043	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1242649	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8022851	usd
	us-gaap	Treasury Stock Value Acquired Par Value Method TreasuryStockValueAcquiredParValueMethod	474	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80611346	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	47257883	usd
	us-gaap	Cost Of Revenue CostOfRevenue	20312854	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	-4132832	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-3528813	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7722014	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11756291	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2313423	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5771588	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	10035437	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	17527879	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-21056692	usd
CY2024Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-8317813	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	410980	usd
CY2024Q3	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-2649477	usd
CY2023Q3	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	0	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80611346	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-78662425	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80611346	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.84
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.84
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.29
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9487842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9487842	shares
CY2023Q3	wkhs	Shares Issued During Period Value Litigation Settlement SharesIssuedDuringPeriodValueLitigationSettlement	20000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8376	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3520404	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-30645712	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	108586931	usd
	wkhs	Shares Issued During Period Shares Litigation Settlement SharesIssuedDuringPeriodSharesLitigationSettlement	1269036	shares
	wkhs	Shares Issued During Period Value Litigation Settlement SharesIssuedDuringPeriodValueLitigationSettlement	20000000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-467214	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10321889	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	112768693	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	83112171	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-171043	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8022851	usd
	us-gaap	Treasury Stock Value Acquired Par Value Method TreasuryStockValueAcquiredParValueMethod	474	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80611346	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	47257883	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80611346	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5959822	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2468832	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1636250	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-143169	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8206673	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10321889	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-1084906	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	112768693	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	58636957	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-143	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	83112171	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1242649	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-171043	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8022851	usd
	us-gaap	Treasury Stock Value Acquired Par Value Method TreasuryStockValueAcquiredParValueMethod	474	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80611346	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	47257883	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80611346	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5959822	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1636250	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-143169	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8206673	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10321889	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-1084906	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-550090	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	580123	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	583348	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2917251	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-785394	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	5295003	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1238803	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28492532	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-641345	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1083886	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2570035	usd
	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-1126224	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40115793	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-95546635	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4027565	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4027565	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16527317	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	28250000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	20000000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4366649	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	52789512	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-903357	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-659582	usd
	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-171043	usd
	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-467214	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11542249	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51662716	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-32601109	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-60411236	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35845915	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99276301	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3244806	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38865065	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80611346	usd
	us-gaap	Net Income Loss NetIncomeLoss	-78662425	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5959822	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2468832	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1636250	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-143169	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8206673	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10321889	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-1084906	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-550090	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	580123	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	583348	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2917251	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10000000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-785394	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	5295003	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1238803	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28492532	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-641345	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1083886	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2570035	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5563625	usd
	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-1126224	usd
	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-430154	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40115793	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-95546635	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4027565	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16527317	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4027565	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16527317	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	28250000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	20000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4366649	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	52789512	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-903357	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-659582	usd
	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-171043	usd
	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-467214	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11542249	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51662716	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-32601109	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-60411236	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35845915	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99276301	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3244806	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38865065	usd
	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	4700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80600000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40100000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3200000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	700000	usd
CY2024Q3	us-gaap	Other Receivables OtherReceivables	3000000	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-550090	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	580123	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	583348	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2917251	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-200000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10000000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-785394	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	5295003	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1238803	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28492532	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-641345	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1083886	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2570035	usd
	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-1126224	usd
	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-430154	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40115793	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-95546635	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4027565	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16527317	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4027565	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	20000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	52789512	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-903357	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-659582	usd
	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-171043	usd
	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-467214	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11542249	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51662716	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-60411236	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35845915	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99276301	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3244806	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38865065	usd
	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	4700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-80600000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40100000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	700000	usd
CY2024Q3	us-gaap	Other Receivables OtherReceivables	3000000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	43200000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10600000	usd
	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	4700000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40100000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3200000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	700000	usd
CY2024Q3	us-gaap	Other Receivables OtherReceivables	3000000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	43200000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10600000	usd
CY2024Q3	wkhs	Working Capital WorkingCapital	7900000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-832200000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	34500000	usd
CY2024Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.20
CY2024Q1	wkhs	Restructuring And Related Cost Executive Payment Deferral Percent RestructuringAndRelatedCostExecutivePaymentDeferralPercent	0.20
CY2024Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	73	employee
	wkhs	Restructuring And Related Cost Number Of Positions Reinstated RestructuringAndRelatedCostNumberOfPositionsReinstated	16	employee
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.</span></div>
CY2024Q3	us-gaap	Inventory Net InventoryNet	43200000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10600000	usd
CY2024Q3	wkhs	Working Capital WorkingCapital	7900000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-832200000	usd
CY2024Q1	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	34500000	usd
CY2024Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.20
CY2024Q1	wkhs	Restructuring And Related Cost Executive Payment Deferral Percent RestructuringAndRelatedCostExecutivePaymentDeferralPercent	0.20
	wkhs	Restructuring And Related Cost Number Of Positions Reinstated RestructuringAndRelatedCostNumberOfPositionsReinstated	16	employee
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.</span></div>
CY2024Q3	wkhs	Working Capital WorkingCapital	7900000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	34500000	usd
CY2024Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.20
CY2024Q1	wkhs	Restructuring And Related Cost Executive Payment Deferral Percent RestructuringAndRelatedCostExecutivePaymentDeferralPercent	0.20
CY2024Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	73	employee
	wkhs	Restructuring And Related Cost Number Of Positions Reinstated RestructuringAndRelatedCostNumberOfPositionsReinstated	16	employee
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.</span></div>
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	32682324	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	46097429	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	32682324	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2892329	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18309829	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	53884482	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	45408192	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12500000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	6824168	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	7908087	usd
CY2024Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1943969	usd
CY2023Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1999068	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4880199	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5909019	usd
CY2024Q3	us-gaap	Prepaid Insurance PrepaidInsurance	864110	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1283146	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1613529	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	908997	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7357838	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8101162	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	32682324	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	4123097	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2892329	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5476095	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	53884482	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	45408192	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12500000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8500000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	6824168	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	7908087	usd
CY2024Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1943969	usd
CY2023Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1999068	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4880199	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5909019	usd
CY2024Q3	us-gaap	Prepaid Insurance PrepaidInsurance	864110	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1283146	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18309829	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	53884482	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8476290	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	45408192	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12500000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8500000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	6824168	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	7908087	usd
CY2024Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1943969	usd
CY2023Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1999068	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4880199	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5909019	usd
CY2024Q3	us-gaap	Prepaid Insurance PrepaidInsurance	864110	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1283146	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1613529	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	908997	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7357838	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8101162	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	53884482	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8476290	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8500000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	7908087	usd
CY2024Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1943969	usd
CY2023Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	1999068	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5909019	usd
CY2024Q3	us-gaap	Prepaid Insurance PrepaidInsurance	864110	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1283146	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1613529	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	908997	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7357838	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1613529	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	908997	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7357838	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8101162	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2509717	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8688423	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6400000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4700000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3935226	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2083808	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	114438	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2024Q3	wkhs	Accrued Sales Returns Allowance AccruedSalesReturnsAllowance	1102005	usd
CY2023Q4	wkhs	Accrued Sales Returns Allowance AccruedSalesReturnsAllowance	0	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8384321	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4862740	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2509717	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3028545	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4691451	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8688423	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6400000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4700000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3935226	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2083808	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	114438	usd
CY2024Q3	wkhs	Accrued Sales Returns Allowance AccruedSalesReturnsAllowance	1102005	usd
CY2023Q4	wkhs	Accrued Sales Returns Allowance AccruedSalesReturnsAllowance	0	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3232652	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8384321	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	642326	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1902647	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2207674	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	61611	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	289404	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	189904	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	884717	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	195708	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	144344	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	454563	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	776423	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2509717	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3028545	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8688423	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6400000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4700000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3935226	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2083808	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	114438	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2024Q3	wkhs	Accrued Sales Returns Allowance AccruedSalesReturnsAllowance	1102005	usd
CY2023Q4	wkhs	Accrued Sales Returns Allowance AccruedSalesReturnsAllowance	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2778932	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8384321	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	642326	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1922580	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1902647	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2207674	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	61611	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	289404	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	189904	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	884717	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	195708	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	144344	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2509717	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3028545	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4691451	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8688423	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6400000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4700000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3935226	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2083808	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	114438	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2024Q3	wkhs	Accrued Sales Returns Allowance AccruedSalesReturnsAllowance	1102005	usd
CY2023Q4	wkhs	Accrued Sales Returns Allowance AccruedSalesReturnsAllowance	0	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3232652	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8384321	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	642326	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1922580	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1902647	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2207674	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	61611	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	189904	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	884717	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	195708	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	144344	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-936320	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	454563	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	776423	usd
CY2024Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	642326	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1922580	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1902647	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2207674	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	61611	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	289404	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	189904	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	884717	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	195708	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	144344	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-936320	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	454563	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	776423	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	776423	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	45829120	usd
CY2024Q3	us-gaap	Share Price SharePrice	0.87
CY2024Q3	us-gaap	Share Price SharePrice	0.87
CY2024Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	63428	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200858	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200733	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	385933	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	614060	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1750431	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1754557	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	449361	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	688118	usd
	us-gaap	Lease Cost LeaseCost	1951289	usd
	us-gaap	Lease Cost LeaseCost	1955290	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3465637	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4174800	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5470933	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5621181	usd
CY2024Q3	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	8936570	usd
CY2023Q4	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	9795981	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-936320	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	454563	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	776423	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	45829120	usd
CY2024Q3	us-gaap	Share Price SharePrice	0.87
CY2024Q3	us-gaap	Share Price SharePrice	0.87
CY2024Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	63428	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	74058	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200858	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200733	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	385933	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	614060	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1750431	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	449361	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	688118	usd
	us-gaap	Lease Cost LeaseCost	1955290	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3465637	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4174800	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5470933	usd
CY2024Q3	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	8936570	usd
CY2023Q4	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	9795981	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1001120	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1012428	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2100635	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2548184	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4556738	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5280526	usd
CY2024Q3	wkhs	Total Lease Liabilities TotalLeaseLiabilities	7658493	usd
CY2023Q4	wkhs	Total Lease Liabilities TotalLeaseLiabilities	8841138	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	776423	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	45829120	usd
CY2024Q3	us-gaap	Share Price SharePrice	0.87
CY2024Q3	us-gaap	Share Price SharePrice	0.87
CY2024Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	74058	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200858	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200733	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	385933	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	614060	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1750431	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1754557	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	449361	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	688118	usd
	us-gaap	Lease Cost LeaseCost	1951289	usd
	us-gaap	Lease Cost LeaseCost	1955290	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3465637	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4174800	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5470933	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5621181	usd
CY2024Q3	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	8936570	usd
CY2023Q4	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	9795981	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1001120	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1012428	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2100635	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2548184	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4556738	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5280526	usd
CY2024Q3	wkhs	Total Lease Liabilities TotalLeaseLiabilities	7658493	usd
CY2023Q4	wkhs	Total Lease Liabilities TotalLeaseLiabilities	8841138	usd
CY2024Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	776423	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1777520	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	45829120	usd
CY2024Q3	us-gaap	Share Price SharePrice	0.87
CY2024Q3	us-gaap	Share Price SharePrice	0.87
CY2024Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	63428	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	74058	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200858	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	200733	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	385933	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	614060	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1750431	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1754557	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	449361	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	688118	usd
	us-gaap	Lease Cost LeaseCost	1951289	usd
	us-gaap	Lease Cost LeaseCost	1955290	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3465637	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4174800	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5470933	usd
CY2024Q3	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	8936570	usd
CY2023Q4	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	9795981	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1001120	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1012428	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2100635	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2548184	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4556738	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5280526	usd
CY2024Q3	wkhs	Total Lease Liabilities TotalLeaseLiabilities	7658493	usd
CY2023Q4	wkhs	Total Lease Liabilities TotalLeaseLiabilities	8841138	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1001120	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1012428	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2100635	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2548184	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4556738	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5280526	usd
CY2024Q3	wkhs	Total Lease Liabilities TotalLeaseLiabilities	7658493	usd
CY2023Q4	wkhs	Total Lease Liabilities TotalLeaseLiabilities	8841138	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	17500000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3000000	shares
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1940256	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3520405	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8206673	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10321890	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	17500000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3000000	shares
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3520405	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8206673	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10321890	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14822	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	205.4
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14822	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y3M
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	14822	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	205.4
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	17500000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3000000	shares
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1940256	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8206673	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10321890	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14822	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	205.4
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	205.4
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	17500000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3000000	shares
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1940256	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3520405	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10321890	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14822	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	205.4
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14822	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	205.4
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y3M
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	14822	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	205.4
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14822	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	205.4
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y3M
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	14822	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	205.4
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M
CY2024Q3	wkhs	Number Of Classes Of Stock NumberOfClassesOfStock	1	class_of_stock
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	wkhs	Common Stock Number Of Votes On Each Share CommonStockNumberOfVotesOnEachShare	1	vote
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	wkhs	Sale Of Stock Authorized Amount SaleOfStockAuthorizedAmount	175000000	usd
CY2024Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	0	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	500000	shares
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	2700000	usd
CY2024Q3	wkhs	Sale Of Stock Remaining Authorized Amount SaleOfStockRemainingAuthorizedAmount	95600000	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	75000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	wkhs	Number Of Classes Of Stock NumberOfClassesOfStock	1	class_of_stock
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	wkhs	Common Stock Number Of Votes On Each Share CommonStockNumberOfVotesOnEachShare	1	vote
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	wkhs	Sale Of Stock Authorized Amount SaleOfStockAuthorizedAmount	175000000	usd
CY2024Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	0	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	500000	shares
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	2700000	usd
CY2024Q3	wkhs	Sale Of Stock Remaining Authorized Amount SaleOfStockRemainingAuthorizedAmount	95600000	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	75000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15600000	shares
CY2024Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2024Q3	wkhs	Number Of Classes Of Stock NumberOfClassesOfStock	1	class_of_stock
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	wkhs	Common Stock Number Of Votes On Each Share CommonStockNumberOfVotesOnEachShare	1	vote
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	wkhs	Sale Of Stock Authorized Amount SaleOfStockAuthorizedAmount	175000000	usd
CY2024Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	0	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	500000	shares
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	2700000	usd
CY2024Q3	wkhs	Sale Of Stock Remaining Authorized Amount SaleOfStockRemainingAuthorizedAmount	95600000	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	75000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15600000	shares
CY2024Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2024Q3	wkhs	Number Of Classes Of Stock NumberOfClassesOfStock	1	class_of_stock
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	wkhs	Common Stock Number Of Votes On Each Share CommonStockNumberOfVotesOnEachShare	1	vote
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	wkhs	Sale Of Stock Authorized Amount SaleOfStockAuthorizedAmount	175000000	usd
CY2024Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	0	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	500000	shares
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	2700000	usd
CY2024Q3	wkhs	Sale Of Stock Remaining Authorized Amount SaleOfStockRemainingAuthorizedAmount	95600000	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	75000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15600000	shares
CY2024Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15600000	shares
CY2024Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	22900000	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	16000000	shares
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	22900000	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	16000000	shares
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	22900000	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	16000000	shares
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	22900000	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	16000000	shares
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001425287-24-000131-index-headers.html	Edgar Link	pending
0001425287-24-000131-index.html	Edgar Link	pending
0001425287-24-000131.txt	Edgar Link	pending
0001425287-24-000131-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
0001425287-24-000131-index-headers.html	Edgar Link	pending
0001425287-24-000131-index.html	Edgar Link	pending
0001425287-24-000131.txt	Edgar Link	pending
0001425287-24-000131-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
0001425287-24-000131-index-headers.html	Edgar Link	pending
0001425287-24-000131-index.html	Edgar Link	pending
0001425287-24-000131.txt	Edgar Link	pending
0001425287-24-000131-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wkhs-20240930.htm	Edgar Link	pending
wkhs-20240930.xsd	Edgar Link	pending
wkhs-20240930xexx311.htm	Edgar Link	pending
wkhs-20240930xexx312.htm	Edgar Link	pending
wkhs-20240930xexx321.htm	Edgar Link	pending
wkhs-20240930xexx322.htm	Edgar Link	pending
wkhs-20240930_cal.xml	Edgar Link	unprocessable
wkhs-20240930_def.xml	Edgar Link	unprocessable
wkhs-20240930_lab.xml	Edgar Link	unprocessable
wkhs-20240930_pre.xml	Edgar Link	unprocessable
wkhs-20240930_htm.xml	Edgar Link	completed
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wkhs-20240930.htm	Edgar Link	pending
wkhs-20240930.xsd	Edgar Link	pending
wkhs-20240930xexx311.htm	Edgar Link	pending
wkhs-20240930xexx312.htm	Edgar Link	pending
wkhs-20240930xexx321.htm	Edgar Link	pending
wkhs-20240930xexx322.htm	Edgar Link	pending
wkhs-20240930_cal.xml	Edgar Link	unprocessable
wkhs-20240930_def.xml	Edgar Link	unprocessable
wkhs-20240930_lab.xml	Edgar Link	unprocessable
wkhs-20240930_pre.xml	Edgar Link	unprocessable
wkhs-20240930_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wkhs-20240930.htm	Edgar Link	pending
wkhs-20240930.xsd	Edgar Link	pending
wkhs-20240930xexx311.htm	Edgar Link	pending
wkhs-20240930xexx312.htm	Edgar Link	pending
wkhs-20240930xexx321.htm	Edgar Link	pending
wkhs-20240930xexx322.htm	Edgar Link	pending
wkhs-20240930_cal.xml	Edgar Link	unprocessable
wkhs-20240930_def.xml	Edgar Link	unprocessable
wkhs-20240930_lab.xml	Edgar Link	unprocessable
wkhs-20240930_pre.xml	Edgar Link	unprocessable
wkhs-20240930_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WKHS
Workhorse Group Inc. Stock $wkhs

2024 Q4 Form 10-Q Financial Statement

#000142528724000131 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS Workhorse Group Inc. Stock $wkhs

2024 Q4 Form 10-Q Financial Statement

#000142528724000131 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS
Workhorse Group Inc. Stock $wkhs